Neurotransmitter may help aggressive prostate cancer shut out immune cells from the start

Дата публикации: 25-09-2026 15:40:23

A new study from The Wistar Institute has found a link between the nervous system and the rapid development of neuroendocrine prostate cancer (NEPC), an aggressive form of the disease. Published in Oncogene, the study found high levels of neuromedin U (NMU), a neurotransmitter, in prostate cells during the earliest phase of NEPC formation.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Prostate-Specific Membrane Antigen Imaging and Initial Treatment for Prostate Cancer	0	10.24	01-07-2026
2	Scientists uncover the hidden nerve network fueling breast cancer	0	8.15	17-08-2026
3	How aggressive breast cancer turns off the immune system	0	5.76	12-04-2026
4	New treatment approach improves survival, reduces recurrence risk in muscle-invasive bladder cancer	0	11.13	24-07-2026
5	FDA gives expedited approval to new groundbreaking pancreatic cancer drug	0	6.49	26-08-2026
6	NHS inviting 500,000 men to join major prostate cancer research programme	0	7.53	01-08-2026
7	Reshaping the gut microbiome can boost chemotherapy delivery to tumors	0	6.61	01-08-2026
8	Long-Term Adverse Effects and Complications After Prostate Cancer Treatment	0	9.73	01-12-2024
9	Scientists turn probiotic bacteria into tiny drug factories for pancreatic cancer	0	10.79	19-08-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 4.51. Источник: medicalxpress.com.